Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments
Antivascular treatments can either be antiangiogenic or targeting established tumour vasculature. These treatments affect the tumour microvasculature and microenvironment but may not change clinical measures like tumour volume and growth. In research on antivascular treatments, information on the tu...
Main Authors: | Michael R. Horsman, Thomas Wittenborn, Thomas Nielsen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/4/4/563 |
Similar Items
-
Quantitative monitoring of paramagnetic contrast agents and their allocation in plant tissues via DCE-MRI
by: Borisjuk, L., et al.
Published: (2022) -
Time-Efficient Perfusion Imaging Using DCE- and DSC-MRI
by: Macíček Ondřej, et al.
Published: (2018-10-01) -
The diagnostic value of combined dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted imaging (DWI) in characterization of parotid gland tumors
by: Mohamed Ali EL-Adalany, et al.
Published: (2020-07-01) -
Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure
by: Hompland Tord, et al.
Published: (2012-11-01) -
Dynamic Contrast Magnetic Resonance Imaging (DCE-MRI) and Diffusion Weighted MR Imaging (DWI) for Differentiation between Benign and Malignant Salivary Gland Tumors
by: Assili S, et al.
Published: (2012-12-01)